X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Orchid Chemicals with AANJANEYA LIFECARE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs DR. DATSONS LABS - Comparison Results

ORCHID PHARMA LTD    Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA LTD DR. DATSONS LABS ORCHID PHARMA LTD/
DR. DATSONS LABS
 
P/E (TTM) x -0.6 -10.9 - View Chart
P/BV x 0.4 0.2 268.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ORCHID PHARMA LTD   DR. DATSONS LABS
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
DR. DATSONS LABS
Mar-14
ORCHID PHARMA LTD/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs194126 154.5%   
Low Rs3531 113.3%   
Sales per share (Unadj.) Rs276.5133.0 207.9%  
Earnings per share (Unadj.) Rs-79.20.2 -52,245.2%  
Cash flow per share (Unadj.) Rs-43.56.6 -657.6%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs53.9128.8 41.9%  
Shares outstanding (eoy) m70.4531.66 222.5%   
Bonus/Rights/Conversions ESOPFCCB-  
Price / Sales ratio x0.40.6 70.4%   
Avg P/E ratio x-1.4516.1 -0.3%  
P/CF ratio (eoy) x-2.611.8 -22.3%  
Price / Book Value ratio x2.10.6 349.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m8,0672,477 325.6%   
No. of employees `0002.8NA-   
Total wages/salary Rs m2,52756 4,512.5%   
Avg. sales/employee Rs Th6,956.1NM-  
Avg. wages/employee Rs Th902.5NM-  
Avg. net profit/employee Rs Th-1,993.0NM-  
INCOME DATA
Net Sales Rs m19,4774,211 462.6%  
Other income Rs m40779 517.4%   
Total revenues Rs m19,8844,289 463.6%   
Gross profit Rs m1,103569 193.9%  
Depreciation Rs m2,519204 1,232.5%   
Interest Rs m5,227430 1,215.0%   
Profit before tax Rs m-6,23613 -49,103.9%   
Minority Interest Rs m200-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m5110-   
Tax Rs m-1256 -2,052.5%   
Profit after tax Rs m-5,5805 -116,256.3%  
Gross profit margin %5.713.5 41.9%  
Effective tax rate %2.048.0 4.2%   
Net profit margin %-28.70.1 -25,132.1%  
BALANCE SHEET DATA
Current assets Rs m11,0146,852 160.8%   
Current liabilities Rs m32,0606,711 477.8%   
Net working cap to sales %-108.13.3 -3,226.7%  
Current ratio x0.31.0 33.6%  
Inventory Days Days95161 59.0%  
Debtors Days Days34318 10.5%  
Net fixed assets Rs m29,4403,673 801.5%   
Share capital Rs m705317 222.5%   
"Free" reserves Rs m2,0433,761 54.3%   
Net worth Rs m3,8004,078 93.2%   
Long term debt Rs m9,0181,671 539.7%   
Total assets Rs m46,51012,633 368.2%  
Interest coverage x-0.21.0 -18.8%   
Debt to equity ratio x2.40.4 579.2%  
Sales to assets ratio x0.40.3 125.6%   
Return on assets %-0.83.4 -22.1%  
Return on equity %-146.90.1 -124,749.3%  
Return on capital %-3.77.7 -48.7%  
Exports to sales %37.922.9 165.4%   
Imports to sales %22.614.3 158.2%   
Exports (fob) Rs m7,378964 765.3%   
Imports (cif) Rs m4,406602 732.0%   
Fx inflow Rs m7,513964 779.4%   
Fx outflow Rs m5,649607 930.5%   
Net fx Rs m1,865357 522.4%   
CASH FLOW
From Operations Rs m1,6821,345 125.1%  
From Investments Rs m-9,860-2,256 437.2%  
From Financial Activity Rs m6,644-1,200 -553.7%  
Net Cashflow Rs m-1,535-2,111 72.7%  

Share Holding

Indian Promoters % 32.3 4.5 713.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.6 0.0 -  
FIIs % 3.3 1.4 244.4%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 94.1 58.8%  
Shareholders   84,811 20,807 407.6%  
Pledged promoter(s) holding % 54.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA LTD With:   DISHMAN PHARMA  ELDER PHARMA  ALEMBIC LTD  PANACEA BIOTECH  WOCKHARDT LTD.  

Compare ORCHID PHARMA LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty at Record Close Yet Again; IT & Realty Stocks Rally(Closing)

Indian share markets extended rally in the final hour of the trade, hitting fresh record highs while the Bank nifty touched 27,000 level for the first time. At the closing bell.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Jan 22, 2018 03:33 PM

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD 5-YR ANALYSIS

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS